SAM
FOLD

Smartleaf Asset Management’s Amicus Therapeutics FOLD Stock Holding History

Smartleaf Asset Management’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$58.1K Buy
4,025
+257
+7% +$3.68K ﹤0.01% 1379
2025
Q4 		$53.7K Buy
3,768
+2,766
+276% +$27.2K ﹤0.01% 1517
2025
Q3 		$7.96K Buy
1,002
+835
+500% +$5.94K ﹤0.01% 2205
2025
Q2 		$990 Sell
167
-292
-64% -$1.88K ﹤0.01% 2482
2025
Q1 		$3.87K Sell
459
-198
-30% -$1.83K ﹤0.01% 2270
2024
Q4 		$6.18K Sell
657
-287
-30% -$2.98K ﹤0.01% 2175
2024
Q3 		$10.1K Buy
944
+44
+5% +$479 ﹤0.01% 1756
2024
Q2 		$8.92K Buy
+900
New +$9.24K ﹤0.01% 1471

Other funds holding FOLD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Smartleaf Asset Management's FOLD Position: Q1 2026 in Review

Smartleaf Asset Management increased its Amicus Therapeutics (FOLD) stake by 6.8% in Q1 2026, buying an estimated $3.68K and bringing the position to 4,025 shares worth $58.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1379.

Smartleaf Asset Management first reported a position in FOLD in Q2 2024 and has held it in 8 quarters since. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

  • Smartleaf Asset Management held 4,025 shares of Amicus Therapeutics worth $58.1K as of Q1 2026.
  • Smartleaf Asset Management bought 257 Amicus Therapeutics shares in Q1 2026, an estimated $3.68K.
  • Amicus Therapeutics made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q1 2026, its #1379 holding.
  • Smartleaf Asset Management first reported a position in Amicus Therapeutics in Q2 2024 and has held it in 8 quarters since.
  • 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on Smartleaf Asset Management's 13F filing for Q1 2026, filed 15 May 2026.